adenosine diphosphate has been researched along with terutroban in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boneu, B; Chatelain, N; Fiessinger, JN; Gaussem, P; Jude, B; Kroumova, M; Reny, JL; Thalamas, C | 1 |
| Bounameaux, H; Cairols, MA; Clement, DL; Coccheri, S; Fiessinger, JN; Fletcher, JP; Hoffmann, U; Turpie, AG | 1 |
2 trial(s) available for adenosine diphosphate and terutroban
| Article | Year |
|---|---|
The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Administration, Oral; Aged; Arachidonic Acid; Area Under Curve; Collagen; Female; Humans; Kinetics; Male; Middle Aged; Naphthalenes; Platelet Aggregation; Platelet Aggregation Inhibitors; Propionates; Receptors, Thromboxane; Time Factors | 2005 |
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Peripheral Arterial Disease; Placebos; Platelet Aggregation; Propionates; Thromboxanes; Time Factors | 2010 |